Literature DB >> 31449440

Risk of Leukemia Associated with Protracted Low-Dose Radiation Exposure: Updated Results from the National Registry for Radiation Workers Study.

Michael Gillies1, Richard Haylock1, Nezhat Hunter1, Wei Zhang1.   

Abstract

While the link between risk of leukemia and acute radiation exposure is well established for large doses received acutely, uncertainty remains around the translation of these risk estimates to occupational exposure scenarios where the doses are low and accumulated over time, possibly over many years. We present leukemia incidence and mortality radiation risk estimates derived from the National Registry for Radiation Workers, which is a large cohort of occupationally exposed workers from the United Kingdom (UK). The cohort comprised 173,081 workers from the UK who were monitored for occupational exposure to radiation. The cohort was followed for a total of 5.3 million person-years and the incidence and mortality due to leukemia was identified through to the end of follow-up in 2011. Poisson regression was used to investigate the relationship between cumulative radiation dose and leukemia mortality and incidence rates using excess relative risk (ERR) and excess additive risk (EAR) models. The results of this work showed a collective dose of 4,414 person-Sv accumulated by the cohort with an average cumulative dose of 25.5 mSv. Among male workers both the ERR and EAR models showed evidence of increased leukemia risk (excluding chronic lymphatic leukemia) associated with increasing cumulative dose. The ERR was 1.38 per Sv (90% CI: 0.04; 3.24) and EAR was 1.33 per 10,000 person-year-Sv (90% CI: 0.04; 2.89) when a linear model was used. These excess risks were driven by increased risks for chronic myeloid leukemia [ERR/Sv = 6.77 (90% CI: 2.14; 15.44)]. In conclusion, this study provides further evidence that leukemia risks may be increased by low-dose and protracted external radiation exposure. The risks are generally consistent with those observed in the atomic bomb survivor studies, as well as with risk coefficients on which international radiation safety standards, including the dose limits and constraints used to control exposures, are based.

Entities:  

Mesh:

Year:  2019        PMID: 31449440     DOI: 10.1667/RR15358.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  5 in total

Review 1.  Protection of the hematopoietic system against radiation-induced damage: drugs, mechanisms, and developments.

Authors:  Yuanyun Wei; Yaqi Gong; Shuang Wei; Yonglin Chen; Jian Cui; Xiang Lin; Yueqiu Yu; Hongxia Yan; Hui Qin; Lan Yi
Journal:  Arch Pharm Res       Date:  2022-08-11       Impact factor: 6.010

2.  Inter-laboratory comparison of gene expression biodosimetry for protracted radiation exposures as part of the RENEB and EURADOS WG10 2019 exercise.

Authors:  M Abend; S A Amundson; C Badie; K Brzoska; R Hargitai; R Kriehuber; G O'Brien; S Schüle; E Kis; S A Ghandhi; K Lumniczky; S R Morton; D Oskamp; P Ostheim; C Siebenwirth; I Shuryak; T Szatmári; M Unverricht-Yeboah; E Ainsbury; C Bassinet; U Kulka; U Oestreicher; Y Ristic; F Trompier; A Wojcik; L Waldner; M Port
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

Review 3.  Influence of Individual Radiosensitivity on the Hormesis Phenomenon: Toward a Mechanistic Explanation Based on the Nucleoshuttling of ATM Protein.

Authors:  Clément Devic; Mélanie L Ferlazzo; Elise Berthel; Nicolas Foray
Journal:  Dose Response       Date:  2020-05-08       Impact factor: 2.658

4.  Transcriptomic profiling reveals gene expression in human peripheral blood after exposure to low-dose ionizing radiation.

Authors:  Fang Fang; Xiaoling Yu; Xiaochun Wang; Xiaojun Zhu; Lantao Liu; Li Rong; Dongsheng Niu; Jue Li
Journal:  J Radiat Res       Date:  2022-01-20       Impact factor: 2.724

Review 5.  Impact of Host, Lifestyle and Environmental Factors in the Pathogenesis of MPN.

Authors:  Gajalakshmi Ramanathan; Brianna M Hoover; Angela G Fleischman
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.